Publication date: Sep 19, 2024
Tuberculosis (TB) is one of the most widespread infectious diseases worldwide, typically persisting in the body as a latent TB infection (LTBI). Patients with type 2 diabetes have an increased risk of LTBI progressing to active TB. Therefore, this study determined the prevalence and predictors of LTBI and assessed the agreement between tuberculin skin test (TST) and interferon-gamma release assay (IGRA) in diagnosing LTBI among type 2 diabetics in Sana’a city, Yemen. A cross-sectional study was conducted among 150 type 2 diabetics in private health facilities in Sana’a in 2023. Data about demographics, diabetes-related characteristics, and potential risk factors for LTBI were collected using a structured questionnaire. Patients were then screened for LTBI using TST and IGRA. Univariate analysis was used to identify LTBI-associated risk factors, and multivariable binary logistic regression was used to identify independent predictors of LTBI. The agreement between TST and IGRA for diagnosing LTBI was assessed using Cohen’s kappa coefficient (_705). LTBI was prevalent among 29. 3% of type 2 diabetics using both types of tests (25. 3% with IGRA and 21. 3% with TST). Male gender was an independent predictor of LTBI (AOR = 4. 4, 95% confidence interval: 1. 30-15. 08; P = 0. 018). However, being employed (AOR = 0. 3, 95% CI: 0. 09-0. 75; P = 0. 013) and longer duration since diabetes diagnosis (AOR = 0. 3, 95% CI: 0. 12-0. 98; P = 0. 046) were identified as predictors of lower LTBI risk. The agreement between TST and IGRA for the diagnosis of LTBI was 88%, with a good and statistically significant agreement between the two test types (_705 = 0. 670; P